You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 338 Emerging insights on the association of tumor molecular phenotype with clinical benefit in metastatic colorectal cancer (mCRC) subjects treated with AB928 + modified FOLFOX-6 (mFOLFOX-6)

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials in progress
338 Emerging insights on the association of tumor molecular phenotype with clinical benefit in metastatic colorectal cancer (mCRC) subjects treated with AB928 + modified FOLFOX-6 (mFOLFOX-6)

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 202075016
Dec 20202606
Jan 20211604
Feb 20212004
Mar 20213604
Apr 20212402
May 2021604
Jun 2021008
Jul 2021003
Aug 2021005
Sep 2021001
Oct 202120020
Nov 202118018
Dec 20212207
Jan 20222004
Feb 20223002
Mar 20221601
Apr 20224008
May 20223000
Jun 20221402
Jul 20221000
Aug 20223004
Sep 20221200
Oct 2022602
Nov 20222403
Dec 20223001
Jan 20231203
Feb 20232601
Mar 20231001
Apr 20232203
May 20231601
Jun 2023400
Jul 20231603
Aug 2023604
Sep 20231403
Oct 20231602
Nov 20232003
Dec 20232801
Jan 20242600
Feb 20243201
Mar 20241201
Apr 20243702
May 20241002
Jun 20242601
Jul 20243006
Aug 20242205
Sep 20242403
Oct 20241606
Nov 20241401
Dec 20242204
Jan 20251407
Feb 2025001
Mar 2025002
Apr 2025003
May 2025002
Jun 2025004
Total10000205